WordNet

move from one place to another; "transfer the data"; "transmit the news"; "transfer the patient to another hospital"
the act of transfering something from one form to another; "the transfer of the music from record to tape suppressed much of the background noise" (同)transference
transferring ownership (同)transference
application of a skill learned in one situation to a different but similar situation (同)transfer of training, carry-over
someone who transfers or is transferred from one position to another; "the best student was a transfer from LSU" (同)transferee
a ticket that allows a passenger to change conveyances
change from one vehicle or transportation line to another; "She changed in Chicago on her way to the East coast" (同)change
transfer somebody to a different position or location of work (同)reassign
move around; "transfer the packet from his trouser pockets to a pocket in his jacket" (同)shift
transfer from one place or period to another; "The ancient Greek story was transplanted into Modern America" (同)transpose, transplant
cause to change ownership; "I transferred my stock holdings to my children"
be a contributing factor; "make things factor into a companys profitability"
any of the numbers (or symbols) that form a product when multiplied together
an independent variable in statistics
anything that contributes causally to a result; "a number of factors determined the outcome"
consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
a concept whose truth can be proved; "scientific hypotheses are not facts"
a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"

PrepTutorEJDIC

(…から…へ)〈人・物〉‘を'『移す』,移転させる,乗り換えさせる《+名〈人・物〉+from+名+to+名》 / (…から…へ)〈権利・財産など〉‘を'譲り渡す,移転する《+名〈権利・財産〉+from+名+to+名》 / 〈絵画・デザインなど〉‘を'写す,転写する / 〈人が〉(ある人・場所から他の人・場所などへ)『移る』,移される;転任する,転任させられる《+from+名+to+名》 / (…から…へ)列車(バスなど)を乗り換える《+from+名+to+名》 / 〈U〉〈C〉(…を)『移すこと』,(…が)移転されること《+of+名》;転任,転校 / 〈C〉移る人(物),移される人(物);転校生,転任者 / 〈C〉乗り換え切符 / 〈C〉乗り換え場所 / 〈C〉写し絵
(…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/09/13 00:43:19」(JST)

wiki en

Transfer factors are essentially small immune messenger molecules that are produced by all higher organisms.^[1] They are an ancient part of the immune system and represent "an archaic dialect in the language of cells."^[2] Transfer factors were originally described as immune molecules that are derived from blood or spleen cells that cause antigen-specific cell-mediated immunity, primarily delayed hypersensitivity and the production of lymphokines, as well as binding to the antigens themselves. They have a molecular weight of approximately 5000 Daltons and are composed entirely of amino acids.^[3] Transfer factors were discovered by Henry Sherwood Lawrence in 1954.^[4] Transfer factor has some promising findings as a target of immune research, but can only be considered an incompletely investigated field that has been essentially lost to history.

A second use of the term transfer factor applies to a likely different entity ^[5] derived from cow colostrum or chicken egg yolk which is marketed as an oral dietary supplement under the same name citing claims of benefit to the immune system.^[6]

History

In 1942, Merrill Chase discovered that cells taken from the peritoneum of Guinea pigs that had been immunized against an antigen could transfer immunity when injected into Guinea pigs that had never been exposed to the antigen; this phenomenon was the discovery of cell-mediated immunity. Subsequent research attempted to uncover how the cells imparted their effects. Henry Sherwood Lawrence, in 1955,^[4] discovered that partial immunity could be transferred even when the immune cells had undergone lysis - indicating that cells did not need to be fully intact in order to produce immune effects.^[7] Dr. Lawrence went on to discover that only the factors less than 8000 Daltons were required to transfer this immunity; he termed these to be "transfer factors".^[4]

The history of cellular derived transfer factor as a treatment effectively ended in the early 1980s. While the research world was initially excited by the discovery of Dr Lawrence and the possibility that a small molecule could effect the immune system, the concept of small molecules having such profound biologic effect had not been proven.^[8] Despite several successes in using transfer factor to treat human disease and uncover immune effects, one then-prominent researcher was exposed for falsifying data related to his work on transfer factor and guinea pigs; effectively casting all of transfer factor science in a negative light.^[8] This scandal was followed shortly thereafter by the discovery of the Interleukin-1 alpha molecule and thus attention further shifted towards research on interleukins. By 1973, it was discovered that blood products could harbor viruses such as hepatitis A, indicating that transfer factor treatments derived from human or cow blood cells had the potential to transmit these diseases. With the eventual discovery of HIV/AIDS as an additional blood-borne disease most researchers viewed a product derived from blood as an unsafe treatment since screening for hepatitis B and HIV/AIDS would not be developed until after 1985.^[9] Some studies using transfer factor have been conducted after the discovery of HIV/AIDS, but almost all have been outside of the United States.

Most recently, transfer factor has been harvested from sources other than blood, and administered orally, as opposed to intravenously. This use of transfer factors from sources other than blood has not been accompanied by the same concerns associated with blood-borne diseases, since no blood is involved. Transfer factor based nutritional supplements have become extremely popular throughout the world.

Transfer factor (immune molecule) scientific claims

To communicate between cells, the immune system employs hormone-like signal substances; transfer factors are one classy of such immune system communication substances. Transfer factors include both inducer/helper functions (Inducer Factors) and regulator functions (Regulator Factors)—historically called "suppressor functions".^[10] The Inducer Factors translate an apparently mature immune response rom the donor to the recipient. Regulator Factors help control overreactions and limit allergies and autoimmune conditions. Transfer factors have been shown to induce an immune response in less than 24 hours.^[10] Transfer factors are not species-specific, thus transfer factors produced by a cow's immune system are just as effective in humans as they are in the cow.

Henry Sherwood Lawrence discovered that blood cells could 'transfer' antigen-specific cell-mediated immunity even after the cells had undergone lysis.^[4] This lymphocyte product is sometimes referred to as "dialyzable leukocyte extract" in the scientific literature due to being an extract from white blood cells undergoing dialysis to remove all molecules larger than ~5000 Daltons.^[11] Studies on cellular transfer factor have involved mostly animal models and small human clinical trials. These studies have demonstrated preliminary evidence of immune modulation as well as some clinical benefits in a handful of diseases, but the studies not been assessed beyond primary sources and the trials should only be considered pre-clinical.^[12]^[13]

Uses

Despite a small modicum of successes,^[13] transfer factor generated from human blood (human-derived), cow spleen (bovine-derived), or mouse spleen (murine derived) is not in routine clinical use today. A trial investigating its ability to immunize children with leukemia against shingles showed promise in a small number of patients, but represents only one of two placebo-controlled studies.^[5]^[14]

Instead, transfer factors derived from cow colostrum and/or chicken eggs yolks are used predominantly today.

Side effects

Colostrum-derived transfer factors

Long-term oral administration of colostrum-derived transfer factors has been shown to be safe.^[15]^[16]

Blood-derived transfer factors

Human-derived transfer factor appears to be safe for use for up to two years and bovine-derived cellular (from blood sources) transfer factor for up to three months. Side effects include fever and swelling and pain at the injection site. Concern has been raised over the possibility of catching Bovine spongiform encephalopathy (Mad Cow Disease) or other diseases from animal blood-derived products. Transfer factors are contraindicated for women who are pregnant or breastfeeding.^[5] When human- and bovine-derived transfer factor are generated from blood cells^[4]^[17] they carry the potential for blood-borne disease such as HIV/AIDS and Hepatitis C.

Transfer factor (dietary supplement) history, claims, and side effects

Colostrum is a form of milk produced by the mammary glands of mammals (including humans) in late pregnancy. It contains multiple immune modulating molecules, including high antibody levels.^[18] Based on studies noting an overlap in the observed in vitro effects between a molecule contained in colostrum called colostrinin and the dialyzable leukocyte extract mentioned above, a hypothesis formed that the two were the same.^[19] There has been no recent research investigations comparing the two entities and thus there is no verifiable evidence that either colostrum or egg whites do or do not contain the cellular product that shares the name transfer factor. The orally available transfer factor is not obtained from humans nor from blood products of any mammal or animal and thus does not carry the presumed risks of contracting blood borne or animal tissue derived diseases. Retailers of dietary supplement transfer factors advice against use by those with an organ transplant or women that are pregnant.

Colostrum/egg derived transfer factors have been promoted as a treatment for a large number of diseases and health concerns but have not been proven in clinical studies.^[5]^[20]^[21] The United States Food and Drug Administration regulates transfer factors as a dietary supplement,^[20] and therefore, sellers of transfer factor products cannot claim that the supplements diagnose, treat, cure, or prevent ay disease. Despite the FDA's regulation of claims made by sellers of transfer factor products, many users have made anecdotal claims of improvement in diseases such as gout, breast cancer, SLE, asthma, kidney insufficiency, endometriosis, uterine cysts, stroke, COPD, high blood pressure, and other conditions—though no clinical studies have provided any verification of these claims.

References

^ Sell, Stewart (1996). Immunology, Immunopathology and Immunity. Stamford, CT: Appleton & Lange. ISBN 0838540643.
^ Lawrence, HS; Borkowsky, W (1983). "A new basis for the immunoregulatory activities of transfer factor--an arcane dialect in the language of cells.". Cellular Immunology. PMID 6227395.
^ Kirkpatrick CH (June 1993). "Structural nature and functions of transfer factors". Ann. N. Y. Acad. Sci. 685: 362–8. doi:10.1111/j.1749-6632.1993.tb35889.x. PMID 8363241.
^ ^a ^b ^c ^d ^e Al-Askari, S (2009). "Henry Sherwood Lawrence". Biographical Memoirs, Volume 90. National Academy of Sciences. pp. 237–255. ISBN 0-309-12148-5.
^ ^a ^b ^c ^d "Transfer Factor". WebMD. Retrieved 2010-02-16.
^ PDR http://www.pdr.net/drugpages/productlabeling.aspx?mpcode=30651060
^ Lawrence, H. S. (1955). "The Transfer in Humans of Delayed Skin Sensitivity to Streptococcal M Substance and to Tuberculin with Disrupted Leucocytes 12". Journal of Clinical Investigation 34 (2): 219–230. doi:10.1172/JCI103075. PMC 438618. PMID 13233344.
^ ^a ^b Chedd, G (1974-12-26). "Transfer factor - Another scandal?". New Scientist 64 (929). pp. 920–1.
^ http://www.bloodbook.com/trans-history.html
^ ^a ^b Lawrence, H. Sherwood; Borkowsky, William (1996). "Transfer Factor—Current status and future prospects". Biotherapy: 1–3. doi:10.1007/BF02628649. Retrieved August 31, 2015.
^ Ojeda, M. O.; van't Veer, C.; Fernández Ortega, C. B.; Araña Rosainz, M. D. J.; Buurman, W. A. (2005). "Dialyzable Leukocyte Extract differentially regulates the production of TNFα, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells". Inflammation Research 54 (2): 74–81. doi:10.1007/s00011-004-1326-5. PMID 15750714.
^ Wang, R. N.; Wang, Y. B.; Geng, J. W.; Guo, D. H.; Liu, F.; Chen, H. Y.; Zhang, H. Y.; Cui, B. A.; Wei, Z. Y. (2012). "Enhancing immune responses to inactivated porcine parvovirus oil emulsion vaccine by co-inoculating porcine transfer factor in mice". Vaccine 30 (35): 5246–5252. doi:10.1016/j.vaccine.2012.05.077. PMID 22705080.
^ ^a ^b Berrón-Pérez, R.; Chávez-Sánchez, R.; Estrada-García, I.; Espinosa-Padilla, S.; Cortez-Gómez, R.; Serrano-Miranda, E.; Ondarza-Aguilera, R.; Pérez-Tapia, M.; Pineda Olvera, B.; Jiménez-Martínez Mdel, C.; Portugués, A.; Rodríguez, A.; Cano, L.; Pacheco, P. U.; Barrientos, J.; Chacón, R.; Serafín, J.; Mendez, P.; Monges, A.; Cervantes, E.; Estrada-Parra, S. (2007). "Indications, usage, and dosage of the transfer factor". Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 54 (4): 134–139. PMID 18297853.
^ Estrada-Parra, S.; Nagaya, A.; Serrano, E.; Rodriguez, O.; Santamaria, V.; Ondarza, R.; Chavez, R.; Correa, B.; Monges, A.; Cabezas, R.; Calva, C.; Estrada-Garcia, I. (1998). "Comparative study of transfer factor and acyclovir in the treatment of herpes zoster". International journal of immunopharmacology 20 (10): 521–535. doi:10.1016/S0192-0561(98)00031-9. PMID 9839657.
^ Pizza, G; De Vinci, C; Fornarola, V; Palareti, A; Baricordi, O; Viza, D (1996). "In vitro studies during long-term oral administration of specific Transfer Factor". Biotherapy.
^ Kirkpatrick, Charles H.; Burger, Denis R.; Lawrence, H. Sherwood, eds. (1983). Immunobiology of Transfer Factor. New York, New York: Academic Press. pp. 261–70. ISBN 1483277682.
^ Kirkpatrick, C. H. (2000). "Transfer factors: Identification of conserved sequences in transfer factor molecules". Molecular medicine (Cambridge, Mass.) 6 (4): 332–341. PMC 1949950. PMID 10949913.
^ McConnell, et al. A comparison of IgG and IgG1 activity in an early milk concentrate from non-immunised cows and a milk from hyperimmunised animals. doi = 10.1016/S0963-9969(00)00163-0
^ Wilson, G. B.; Poindexter, C.; Fort, J. D.; Ludden, K. D. (1988). "De novo initiation of specific cell-mediated immune responsiveness in chickens by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk". Acta virologica 32 (1): 6–18. PMID 2897772.
^ ^a ^b "Transfer Factor". Memorial Sloan–Kettering Cancer Center. 2009-10-08. Retrieved 2010-02-16.
^ Barrett, S (2007-03-28). "Be Wary of Multiple Sclerosis "Cures"". Quackwatch. Retrieved 2010-02-12.

External links

Transfer factor at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 一酸化炭素拡散能 diffusing capacity for carbon monoxide
2. 成人における肺機能検査の概要 overview of pulmonary function testing in adults
3. 自家造血幹細胞移植の適格性判定 determining eligibility for autologous hematopoietic cell transplantation
4. 同種造血細胞移植の適格性判定 determining eligibility for allogeneic hematopoietic cell transplantation
5. 計算ツール：一酸化炭素肺拡散能力（DLCO）（貧血補正） calculator diffusing capacity for carbon monoxide dlco corrected for anemia

English Journal

Silver nanoparticles-enhanced time-resolved fluorescence sensor for VEGF165 based on Mn-doped ZnS quantum dots.

Zhu D1, Li W2, Wen HM3, Yu S3, Miao ZY3, Kang A3, Zhang A3.
Biosensors & bioelectronics.Biosens Bioelectron.2015 Dec 15;74:BIOSD1501314. doi: 10.1016/j.bios.2015.08.005. Epub 2015 Aug 6.
A silver nanoparticles (AgNPs)-enhanced time-resolved fluorescence (TR-FL) sensor based on long-lived fluorescent Mn-doped ZnS quantum dots (QDs) is developed for the sensitive detection of vascular endothelial growth factor-165 (VEGF165), a predominant cancer biomarker in cancer angiogenesis. The a
PMID 26276542

A high sensitive electrochemical aptasensor for the determination of VEGF165 in serum of lung cancer patient.

Amouzadeh Tabrizi M1, Shamsipur M2, Farzin L3.
Biosensors & bioelectronics.Biosens Bioelectron.2015 Dec 15;74:764-9. doi: 10.1016/j.bios.2015.07.032. Epub 2015 Jul 17.
Herein, a label free electrochemical aptasensor based on ordered mesoporous carbon-gold nanocomposite modified screen printed electrode has been fabricated for the detection of vascular endothelial growth factor (VEGF165) as a tumor marker. The electrochemical behavior of prepared biosensor was inve
PMID 26217879

Highly sensitive label free electrochemical detection of VGEF165 tumor marker based on "signal off" and "signal on" strategies using an anti-VEGF165 aptamer immobilized BSA-gold nanoclusters/ionic liquid/glassy carbon electrode.

Shamsipur M1, Farzin L2, Amouzadeh Tabrizi M3, Molaabasi F4.
Biosensors & bioelectronics.Biosens Bioelectron.2015 Dec 15;74:369-75. doi: 10.1016/j.bios.2015.06.079. Epub 2015 Jul 2.
In this work, a label free electrochemical aptasensor for the detection of ultra-traces of vascular endothelial growth factor (VEGF165) based on "signal off" and "signal on" mechanisms of response was developed. The BSA-gold nanoclusters/ionic liquid (BSA-AuNCs/IL) was used as a suitable nanocomposi
PMID 26162327

Japanese Journal

Current-Driven Motion of Magnetic Domain Wall with Many Bloch Lines

Iwasaki Junichi,Nagaosa Naoto
Journal of the Physical Society of Japan 84(8), 2015-07-06
NAID 160000000795

Relationship between information and energy carried by photons in extreme ultraviolet lithography: Consideration from the viewpoint of sensitivity enhancement

Fujii Shinya,Kozawa Takahiro,Okamoto Kazumasa,Santillan Julius,Itani Toshiro
Jpn. J. Appl. Phys. 54(8), 086502, 2015-07-01
… The role of photons in lithography is to transfer information and energy for imaging. … The factor limiting the resist performance (information or energy) depended on the relationship between the resist requirement and the potential performance. … The determination of the limiting factor is essential in designing highly sensitive resist materials. …
NAID 150000111194

Relation between FQHE Plateau Width and Valley Energy

Sasaki Shosuke
Journal of Modern Physics 2015(6), 955-971, 2015-06-30
… The electron pairs placed in the Landau orbitals can transfer to many empty orbitals. … The number of the quantum transitions decreases discontinuously when the filling factor ν deviates from the specific fractional number of ν0. … The energy per electron has the discontinuous spectrum depending on the filling factor ν. …
NAID 120005619882